Improving medication adherence for people living with HIV
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
This study is looking for ways to help people with HIV stick to their daily medication routine by linking it to their regular habits and offering reminders and small rewards, making it easier and more fun to take their pills consistently.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-10925797 on NIH RePORTER |
What this research studies
This research focuses on enhancing long-term adherence to antiretroviral therapy (ART) among individuals living with HIV. It employs a novel approach that combines behavioral economics with established routines, encouraging participants to anchor their ART pill-taking to existing daily habits. Participants will receive daily reminder messages and may earn small incentives for consistent medication adherence, aiming to make the process easier and more engaging. The study seeks to understand how these strategies can help individuals maintain their medication schedules over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are currently prescribed antiretroviral therapy and may struggle with medication adherence.
Not a fit: Patients who are not currently on antiretroviral therapy or those who have no issues with medication adherence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence rates among people living with HIV, leading to better health outcomes and viral suppression.
How similar studies have performed: Previous studies have shown promise in using behavioral economics and routine anchoring to improve medication adherence, indicating that this approach could be effective.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Linnemayr, Sebastian — Rand Corporation
- Study coordinator: Linnemayr, Sebastian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.